Original Research
Published on 11 Nov 2025
Immune checkpoint inhibitors continuation beyond progression as second-line treatment for extensive-stage small-cell lung cancer: a real-world, multicenter analysis
in Cancer Immunity and Immunotherapy
- 478 views